We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+5.27%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$292M
AUM Growth
-$14.9M
Cap. Flow
-$18.4M
Cap. Flow %
-6.3%
Top 10 Hldgs %
7.58%
Holding
892
New
321
Increased
121
Reduced
151
Closed
299

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.21M
2
LEN icon
Lennar Class A
LEN
+$2.54M
3
WEX icon
WEX
WEX
+$2.44M
4
IP icon
International Paper
IP
+$2.42M
5
CAG icon
Conagra Brands
CAG
+$2.39M

Top Sells

Rank Stock Value
1
TD icon
Toronto Dominion Bank
TD
+$3.03M
2
NSC icon
Norfolk Southern
NSC
+$3.03M
3
DPZ icon
Domino's
DPZ
+$2.72M
4
TMUS icon
T-Mobile US
TMUS
+$2.63M
5
FNB icon
FNB Corp
FNB
+$2.09M

Sector Composition

Rank Sector Weight
1 Technology 19.16%
2 Financials 13.05%
3 Consumer Discretionary 12.84%
4 Healthcare 12.81%
5 Industrials 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAM icon
601
Akamai
AKAM
$17.8B
-5,645
Closed -$590K
ALLY icon
602
Ally Financial
ALLY
$13.3B
-16,050
Closed -$819K
ALNY icon
603
Alnylam Pharmaceuticals
ALNY
$29.9B
-1,300
Closed -$245K
ALSN icon
604
Allison Transmission
ALSN
$10.2B
-13,384
Closed -$473K
ALT icon
605
Altimmune
ALT
$603M
-23,300
Closed -$264K
AMAT icon
606
Applied Materials
AMAT
$436B
-4,051
Closed -$521K
AME icon
607
Ametek
AME
$59.1B
-11,700
Closed -$1.45M
AMED
608
DELISTED
Amedisys
AMED
-5,450
Closed -$813K
AMGN icon
609
Amgen
AMGN
$224B
-3,119
Closed -$663K
AMKR icon
610
Amkor Technology
AMKR
$14.1B
-8,021
Closed -$200K
APD icon
611
Air Products & Chemicals
APD
$68.2B
-6,900
Closed -$1.77M
APPS icon
612
Digital Turbine
APPS
$1.51B
-3,150
Closed -$217K
AR icon
613
Antero Resources
AR
$11.7B
-58,000
Closed -$1.09M
ASB icon
614
Associated Banc-Corp
ASB
$6.02B
-9,450
Closed -$202K
ASND icon
615
Ascendis Pharma A/S
ASND
$16.8B
-2,900
Closed -$462K
ATI icon
616
ATI
ATI
$31.7B
-47,197
Closed -$785K
ATKR icon
617
Atkore
ATKR
$3.17B
-5,200
Closed -$452K
AVNS
618
DELISTED
Avanos Medical
AVNS
-22,100
Closed -$690K
AXP icon
619
American Express
AXP
$229B
-6,050
Closed -$1.01M
AXS icon
620
AXIS Capital
AXS
$7.38B
-5,566
Closed -$256K
BANF icon
621
BancFirst
BANF
$3.82B
-4,200
Closed -$253K
BANR icon
622
Banner Corp
BANR
$2.47B
-7,200
Closed -$398K
BCO icon
623
Brink's
BCO
$4.68B
-4,650
Closed -$294K
BHF icon
624
Brighthouse Financial
BHF
$3.4B
-8,000
Closed -$362K
BIO icon
625
Bio-Rad Laboratories Class A
BIO
$9.44B
-350
Closed -$261K

Similar funds

Campbell & Co Investment Adviser's Q4 2021 Portfolio in Review

As of Q4 2021, Campbell & Co Investment Adviser held 892 positions worth $292M, down 4.9% from $307M the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Campbell & Co Investment Adviser withdrew a net $18.4M in Q4 2021, closing 299 positions and reducing 151 holdings. Its most notable exit was Toronto Dominion Bank, an estimated $3.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Campbell & Co Investment Adviser opened a new position in Medtronic worth $2.87M.

  • Campbell & Co Investment Adviser's largest Q4 2021 buy was Medtronic: 27,750 shares worth $2.87M.
  • Campbell & Co Investment Adviser added most to Regions Financial in Q4 2021, an estimated $1.47M increase.
  • Campbell & Co Investment Adviser's biggest Q4 2021 reduction was ExxonMobil, cutting an estimated $1.9M.
  • Campbell & Co Investment Adviser fully exited Toronto Dominion Bank in Q4 2021, selling an estimated $3.03M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.6% of its $292M portfolio in Q4 2021.
  • Campbell & Co Investment Adviser opened 321 new positions and closed 299 in Q4 2021.
  • Campbell & Co Investment Adviser's portfolio value fell 4.9% quarter-over-quarter to $292M.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2021, filed 10 Feb 2022.